Research Peptides · Cat. 019-30
Urocortin II (Human)
Supplied as 100 µg per unit. Purity ≥ 95%. Molecular weight 4153.93. Species: Human. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.
Specifications
| Catalog number | 019-30 |
|---|---|
| Product type | Research Peptides |
| Peptide family | Urocortin |
| Species | Human |
| Unit size | 100 µg |
| Molecular weight | 4153.93 Da |
| Purity | ≥ 95% |
| Validation | Exhibits correct molecular weight |
| Appearance | White powder |
| Contents | Each vial contains 100 µg of NET peptide. Plasma urocortin levels in the diagnosis of ovarian endometriosis. Florio P, Reis FM, Torres PB, et al. Obstet Gynecol. 2007;110(3):594-600. Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats. Muramatsu T, Inoue K, Iwasaki S, Yamauchi T, Hayashi T, Kiriike N. Pharmacol Biochem Behav. 2006;85(2):435-40. High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension. Florio P, Torricelli M, De falco G, et al. J Hypertens. 2006;24(9):1831-40. Maternal plasma corticotrophin-releasing factor and urocortin levels in post-term pregnancies. Torricelli M, Ignacchiti E, Giovannelli A, et al. Eur J Endocrinol. 2006;154(2):281-5. High fetal urocortin levels at term and preterm labor. Florio P, Torricelli M, Galleri L, et al. J Clin Endocrinol Metab. 2005;90(9):5361-5. Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells. Aggelidou E, Hillhouse EW, Grammatopoulos DK. Proc Natl Acad Sci USA. 2002;99(5):3300-5. |
| Solubility | Insoluble in water. Dissolve in a small amount of DMSO or 60% acetonitrile in water with 0.1% TFA. Then dilute with water or any desired buffer. |
| Intended use | In vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes |
Sequence
Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-NH2
Storage & handling
Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.
Confirm handling and preparation requirements against current product documentation and the requirements of your laboratory protocol.
Frequently asked
What is Urocortin II (Human)?
What purity is listed for 019-30?
How should Urocortin II (Human) be stored?
What is the sequence of Urocortin II (Human)?
What is the intended use of 019-30?
This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.